Sean McAuliffe

Corporate Officer/Principal presso TAYSHA GENE THERAPIES, INC.

Health Technology

Profilo

Sean McAuliffe is currently the Chief Business Officer at Taysha Gene Therapies, Inc. Prior to his current position, he served as the Vice President-Marketing at Novartis Gene Therapies, Inc. from 2018 to 2020.

Posizioni attive di Sean McAuliffe

Società	Posizione	Inizio
TAYSHA GENE THERAPIES, INC.	Corporate Officer/Principal	01/06/2020

Tutte le posizioni attive di Sean McAuliffe

Precedenti posizioni note di Sean McAuliffe

Società	Posizione	Fine
AVEXIS INC	Vendite & Marketing	01/06/2020

Vedi nel dettaglio l'esperienza di Sean McAuliffe

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sean McAuliffe

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
TAYSHA GENE THERAPIES, INC.	Health Technology

Aziende private	1
Novartis Gene Therapies, Inc. Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL.	Health Technology